Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Ibrutinib plus venetoclax for relapsed/refractory mantle cell lymphoma: Final analysis of the phase 3 SYMPATICO study.

British journal of haematology·2026

Same author

Magrolimab Plus Azacitidine Versus Placebo Plus Azacitidine in Patients With Untreated Higher-Risk Myelodysplastic Syndromes: The Phase III ENHANCE Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Same author

Biology of p53 protein isoforms and their significance in hematological malignancies.

Frontiers in oncology·2026

Same author

Diving into the transcriptional landscape of leukemic stem cells in acute myeloid leukemia at single-cell resolution.

Journal of cancer research and clinical oncology·2026

Same author

The long-term efficacy and safety of high-dose chemotherapy with autologous stem cell transplantation in the treatment of primary central nervous system lymphoma: A real-world report from the Polish Lymphoma Research Group.

European journal of cancer (Oxford, England : 1990)·2026

Same author

Daratumumab-Bortezomib-Cyclophosphamide-Dexamethasone in Newly Diagnosed Amyloidosis: ANDROMEDA Final Survival Analysis.

Blood·2026

Search research articles

Related Experiment Video

Updated: Aug 9, 2025

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

A Stepwise Screening Protocol for Multiple Myeloma.

Marta Morawska¹, Jadwiga Dwilewicz-Trojaczek², Tomasz Stompór³

¹Experimental Hematooncology Department, Medical University of Lublin & Hematology Department, St. John's Cancer Center, 20-093 Lublin, Poland.

Journal of Clinical Medicine

|February 25, 2023

Summary

Primary care physicians can efficiently screen for monoclonal gammopathies using a developed 3-step protocol. This strategy aids early diagnosis of multiple myeloma and related conditions, improving patient outcomes.

Keywords:

monoclonal gammopathy multiple myeloma screening

More Related Videos

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

Related Experiment Videos

Last Updated: Aug 9, 2025

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

Area of Science:

Hematology
Oncology
Primary Care Medicine

Background:

Monoclonal gammopathies and multiple myeloma require early detection.
Screening in primary care settings is crucial for timely diagnosis.

Purpose of the Study:

To develop and evaluate an efficient screening strategy for monoclonal gammopathies in primary care.
To standardize the diagnostic approach for multiple myeloma.

Main Methods:

A 3-step screening protocol was developed based on multiple myeloma patient characteristics.
Initial interview, basic laboratory tests, and workload analysis informed the strategy.
Evaluation included myeloma-related bone disease, renal function, and hematologic markers.

Main Results:

The protocol identified patients with monoclonal gammopathy through specific laboratory test combinations (ESR, CRP).
Testing identified 900 patients with elevated ESR and normal CRP, 10.4% of whom had positive immunofixation.
The screening strategy proved efficient in diagnosing monoclonal gammopathy.

Conclusions:

The proposed screening strategy enables efficient diagnosis of monoclonal gammopathy.
A stepwise approach rationalizes diagnostic workload and screening costs.
The protocol supports primary care physicians in managing potential multiple myeloma cases.